person

Annamaria B.

Country
Germany
Department
Hämatologie, Hämostaseologie, Onkologie und Stammzelltransplantation

Research Overview

Data & Insights

medical_services
Primary Speciality
Main therapeutic area

handshake
Return Partnerships
Recurring site collaborations
95
Sites with multiple studies

Has run more than one trial at 95 of 233 partner sites.

Specializations

Multiple Myeloma Treatment

The investigator specializes in hematologic oncology with a primary focus on developing innovative therapeutic approaches for multiple myeloma. Their research encompasses both newly diagnosed cases and relapsed/refractory disease states.

  • Novel Combination Therapies
  • Maintenance Treatment Strategies
  • Immunotherapy Applications

Particular attention is given to optimizing treatment outcomes through targeted therapeutic combinations and novel drug delivery methods.

Advanced Therapeutic Approaches

The investigator explores cutting-edge treatments including CAR T-cell therapy and monoclonal antibodies. Their work includes evaluation of novel agents such as iberdomide and isatuximab for various stages of myeloma treatment.

  • Stem Cell Transplantation
  • Targeted Therapies
  • Drug Administration Routes

Focus areas include improving treatment efficacy and developing personalized therapeutic strategies.

Clinical Assessment Methods

Expertise in evaluating treatment responses through advanced diagnostic techniques, including minimal residual disease assessment and standardized response criteria in hematologic malignancies.

  • Response Evaluation Protocols
  • Disease Monitoring
  • Treatment Optimization

Implementation of sophisticated monitoring approaches to guide therapeutic decisions and improve patient outcomes.

Related Investigators

Researchers in similar fields or departments

Want to know more about this investigator?

We can share extended profile information and contact details.

Is something out of date?

Tell us what needs correcting and we'll update this profile.